cyclopentane has been researched along with Primary Myelofibrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Celik, H; Challen, GA; Collins, TB; De Togni, ES; Fisher, DAC; Fulbright, MC; Kong, T; Laranjeira, ABA; Oh, ST; Ruzinova, M; Wong, AJ | 1 |
1 other study(ies) available for cyclopentane and Primary Myelofibrosis
| Article | Year |
|---|---|
Pevonedistat targets malignant cells in myeloproliferative neoplasms in vitro and in vivo via NFκB pathway inhibition.
Topics: Animals; Cyclopentanes; Humans; Leukemia, Myeloid, Acute; Mice; Myeloproliferative Disorders; Primary Myelofibrosis; Pyrimidines | 2022 |